During the past decade, Maternité Port Royal conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maternité Port Royal" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 4 trials, followed by "Ferring Pharmaceuticals" with 1 trials sponsored, "Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux" with 1 trials sponsored, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials sponsored and "University Hospital, Toulouse" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maternité Port Royal" #1 collaborator was "Agence Regionale de Sante d'Ile de France" with 1 trials as a collaborator, "INSERM U1153" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator and "National Agency of Public Health" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Maternité Port Royal" are "Pregnancy" (2 trials), "Pregnant Women" (2 trials), "Controlled Ovarian Stimulation" (1 trials), "Healthcare Worker Patient Transmission" (1 trials) and "Immediate Postpartum Hemorrhage" (1 trials). Many other conditions were trialed in "Maternité Port Royal" in a lesser frequency.

Most popular intervention types in "Maternité Port Royal" are "Other" (2 trials), "Procedure" (2 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cervicovaginal swab" (1 trials), "Clinical signs of placental separation" (1 trials), "Follitropin Delta" (1 trials), "Pessary" (1 trials) and "With cervical dilatator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maternité Port Royal" are 7 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Maternité Port Royal". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Maternité Port Royal, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maternité Port Royal, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".